Larimar Therapeutics (LRMR) Capital Expenditures (2013 - 2025)
Larimar Therapeutics' Capital Expenditures came in at $91,000 for FY2025, down 82.3% from $515,000 in FY2024.
Powered by 
Analysis
Larimar Therapeutics (LRMR) Capital Expenditures (2013 - 2025) Analysis & Trends
Going back to FY2012, Larimar Therapeutics' Capital Expenditures data covers 14 years.
- Capital Expenditures carries a five-year compound annual growth rate of 8.0% (FY2020 to FY2025).
- The FY2025 figure represents the lowest annual Capital Expenditures since FY2020.
- Per Business Quant, earlier years put Capital Expenditures at $515,000 in FY2024 (+214.0%), $164,000 in FY2023 (+64.0%), $100,000 in FY2022 (-70.0%) and $333,000 in FY2021 (+437.1%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Larimar Therapeutics | 329.31 Mn | -277.77 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 23,000.00 |
| Jun 30, 2025 | 19,000.00 |
| Mar 31, 2025 | 49,000.00 |
| Dec 31, 2024 | 179,000.00 |
| Sep 30, 2024 | 62,000.00 |
| Dec 31, 2021 | 9,000.00 |
| Sep 30, 2021 | 293,000.00 |
| Dec 31, 2020 | -1,000.00 |
| Sep 30, 2020 | 5,000.00 |
| Mar 31, 2020 | 58,000.00 |
| Dec 31, 2019 | 50,000.00 |
| Jun 30, 2019 | 31,000.00 |
| Mar 31, 2019 | 2,000.00 |
| Dec 31, 2018 | 12,000.00 |
| Sep 30, 2018 | 76,000.00 |
| Jun 30, 2018 | 19,000.00 |
| Mar 31, 2018 | 1,000.00 |
| Dec 31, 2017 | 27,000.00 |
| Sep 30, 2017 | 12,000.00 |
| Jun 30, 2017 | 6,000.00 |
API Access
Larimar Therapeutics Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=LRMR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "LRMR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=LRMR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();